Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

365 ARTÍCULOS , VIENDO DEL 301 AL 315

The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease

Ritchie CW, Russ TC, Banerjee S, Barber B, Boaden A, Fox NC, Holmes C, Isaacs JD, Leroi I, Lovestone S, Norton M, O'Brien J, Pearson J, Perry R, Pickett J, Waldman AD, Wong WL, Rossor MN, Burns A.

Alzheimers Res Ther. 2017 Oct 26;9(1):85. doi: 10.1186/s13195-017-0312-4.

Recent Progress in the Pharmacotherapy of Alzheimer's Disease

Khoury R, Patel K, Gold J, Hinds S, Grossberg GT.

Drugs Aging. 2017 Nov;34(11):811-820. doi: 10.1007/s40266-017-0499-x.

The Role of Chromatography in Alzheimer's Disease Drug Discovery

Fiori J, De Simone A, Naldi M, Andrisano V.

Adv Chromatogr. 2017;53:75-107.

Impact of functional alterations on quality of life in patients with Alzheimer's disease

Barbe C, Morrone I, Wolak-Thierry A, Dramé M, Jolly D, Novella JL, Mahmoudi R.

Aging Ment Health. 2017 May;21(5):571-576. doi: 10.1080/13607863.2015.1132674. Epub 2016 Jan 8.

Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease

Ismaili L, Refouvelet B, Benchekroun M, Brogi S, Brindisi M, Gemma S, Campiani G, Filipic S, Agbaba D, Esteban G, Unzeta M, Nikolic K, Butini S, Marco-Contelles J.

Prog Neurobiol. 2017 Apr;151:4-34. doi: 10.1016/j.pneurobio.2015.12.003. Epub 2016 Jan 18.

Outcome of a Targeted Nutritional Intervention Among Older Adults With Early-Stage Alzheimer's Disease: The Nutrition Intervention Study

Shatenstein B, Kergoat MJ, Reid I.

J Appl Gerontol. 2017 Jul;36(7):782-807. doi: 10.1177/0733464816628512. Epub 2016 Feb 1.

Resveratrol and Alzheimer's Disease: Mechanistic Insights

Ahmed T, Javed S, Javed S, Tariq A, Šamec D, Tejada S, Nabavi SF, Braidy N, Nabavi SM.

Mol Neurobiol. 2017 May;54(4):2622-2635. doi: 10.1007/s12035-016-9839-9. Epub 2016 Mar 19.

Analysis of recent failures of disease modifying therapies in Alzheimer's disease suggesting a new methodology for future studies

Amanatkar HR, Papagiannopoulos B, Grossberg GT.

Expert Rev Neurother. 2017 Jan;17(1):7-16. doi: 10.1080/14737175.2016.1194203. Epub 2016 Jun 9.

Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer's disease pathology

Tramutola A, Arena A, Cini C, Butterfield DA, Barone E.

Expert Rev Neurother. 2017 Jan;17(1):59-75. doi: 10.1080/14737175.2017.1246183. Epub 2016 Oct 20.

Concentration of Donepezil in the Cerebrospinal Fluid of AD Patients: Evaluation of Dosage Sufficiency in Standard Treatment Strategy

Valis M, Masopust J, Vysata O, Hort J, Dolezal R, Tomek J, Misik J, Kuca K, Karasova JZ.

Neurotox Res. 2017 Jan;31(1):162-168. doi: 10.1007/s12640-016-9672-y. Epub 2016 Oct 7.

Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial)

Knapp M, King D, Romeo R, Adams J, Baldwin A, Ballard C, Banerjee S, Barber R, Bentham P, Brown RG, Burns A, Dening T, Findlay D, Holmes C, Johnson T, Jones R, Katona C, Lindesay J, Macharouthu A, McKeith I, McShane R, O'Brien JT, Phillips PPJ, Sheehan B, Howard R.

Int J Geriatr Psychiatry. 2017 Dec;32(12):1205-1216. doi: 10.1002/gps.4583. Epub 2016 Oct 13.

Adaptive working memory strategy training in early Alzheimer's disease: randomised controlled trial

Huntley JD, Hampshire A, Bor D, Owen A, Howard RJ.

Br J Psychiatry. 2017 Jan;210(1):61-66. doi: 10.1192/bjp.bp.116.182048. Epub 2016 Oct 6.

Molecular and Therapeutic Targets of Genistein in Alzheimer's Disease

Devi KP, Shanmuganathan B, Manayi A, Nabavi SF, Nabavi SM.

Mol Neurobiol. 2017 Nov;54(9):7028-7041. doi: 10.1007/s12035-016-0215-6. Epub 2016 Oct 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias